MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Safety Profile of Opicapone in Elderly and Very Elderly Population

    D. Lopes, I. Peixoto, D. Martins, H. Brigas, H. Gama, J. Holenz (Coronado, Portugal)

    Objective: This study aimed to characterize the safety profile of opicapone (OPC) in the elderly and compare post-marketing safety between (A) very elderly patients (≥…
  • 2025 International Congress

    Three-Year Single-Center Experience with Levodopa–Entacapone–Carbidopa Intestinal Gel in Advanced Parkinson’s Disease

    J. Szász, V. Constantin, K. Orbán-Kis, S. Bataga, R. Neagoe, M. Ciorba, K. Kelemen, I. Mihály, S. Szatmári (TARGU MURES, Romania)

    Objective: To evaluate the efficacy of Levodopa-Entacapone-Carbidopa Intestinal Gel (LECIG) in advanced Parkinson’s Disease (APD). Background: LECIG infusion has been available in Romania since 2021.…
  • 2025 International Congress

    Treatment Stability Across Different ADD-ON Therapies in Fluctuating Parkinson’s Disease

    D. Rinaldi, E. Bianchini, S. Galli, G. Imbalzano, CA. Artusi (Rome, Italy)

    Objective: This study investigates the efficacy and tolerability of selegiline (SL), rasagiline (RS), safinamide (SF), and opicapone (OP) in fluctuating PD patients, focusing on treatment…
  • 2025 International Congress

    Effect of COVID-19 Pandemic on Utilization of Parkinson’s Medications in Saudi Arabia: A Repeated Cross-Sectional Study

    K. Orayj (Abha, Saudi Arabia)

    Objective: This study aims to examine the effects of the pandemic on the patterns of medication usage for Parkinson’s Disease (PD) in Saudi Arabia. Background:…
  • 2025 International Congress

    Mapping aggregate monopolar sensing data of beta power local field potentials onto a common subthalamic nucleus in Parkinson’s disease patients

    M. Case, C. Zarns, A. Holt-Becker, R. Raike, E. Radcliffe, A. Baumgartner, J. Thompson, D. Kern (Minneapolis, USA)

    Objective: Compare local field potential (LFP) magnitude and anatomical location measured from a chronically implanted deep brain stimulation (DBS) lead within the subthalamic nucleus (STN)…
  • 2025 International Congress

    Sleep-wake Alterations are Associated with a Decreased DTI-ALPS, a Marker of Perivascular Glymphatic Functioning, in Patients with Isolated REM Sleep Behavior Disorder

    I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, C. Garcia-Vicente, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, J. Madrir, M. Rol, A. Adan, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)

    Objective: We aimed to explore circadian disruption in iRBD and its association with the Diffusion Tensor Imaging- ALong the Perivascular Space (DTI-ALPS) index, a proxy…
  • 2025 International Congress

    Quantitative Measures of Cutaneous Phosphorylated Alpha-Synuclein: Powering a Disease Modification Clinical Trial In Parkinson’s Disease

    C. Gibbons, B. Bellaire, H. Khona, T. Levine, R. Freeman, B. Li, M. Dey, B. Henderson (Boston, USA)

    Objective: To use a novel quantitative assessment of cutaneous P-SYN in a pilot study of patients with Parkinson’s disease (PD) and healthy volunteers (HVs) to…
  • 2025 International Congress

    Relationship Between Motor Subtypes and Central and Peripheral Neurodegeneration in Early Parkinson’s Disease: A Study Using DAT SPECT and SUDOSCAN

    T. Shimizu, S. Moriyasu, K. Taneda, N. Tokuda, Y. Ugawa, R. Hanajima (Tokyo, Japan)

    Objective: To investigate the relationship between Parkinson’s disease (PD) motor subtypes and neurodegeneration in both the central and peripheral nervous systems using dopamine transporter single-photon emission…
  • 2025 International Congress

    Tracking cortical and peripheral beta bursts in Parkinson’s disease during DBS modulation

    C. Graef, V. Rawji, N. Steadman, T. Foltynie, Y. Tai, R. Vaidyanathan, D. Farina, S. Haar (London, United Kingdom)

    Objective: We examined the relationship between cortical and peripheral beta bursts during symptom fluctuations in Parkinson’s disease (PD), and their response to deep brain stimulation…
  • 2025 International Congress

    Plasma neurofilament light chain in early Parkinson’ s disease predicts motor complications: A Prospective Cohort Study

    NN. Che (Chengdu, Sichuan, China)

    Objective: The current study aimed to identify risk plasma biomarkers in early-stage PD for future motor complications through a longitudinal Chinese PD cohort, which ultimately…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley